ANI Pharmaceuticals Inc (ANIP) — Financial Flexibility Index
ANI Pharmaceuticals Inc (ANIP) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of $54.23 Million (operating CF $30.37 Million minus capex $23.86 Million) represents 0% of total liabilities ($899.65 Million). Check cash flow reinvestment rate of ANI Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ANI Pharmaceuticals Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for ANI Pharmaceuticals Inc across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of ANI Pharmaceuticals Inc.
Annual Financial Flexibility Index for ANI Pharmaceuticals Inc (1998–2025)
Year-by-year free cash flow to debt coverage for ANI Pharmaceuticals Inc. Explore how well can ANI Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | $199.06 Million | $185.22 Million | $899.65 Million | ▲ +133.7% |
| 2024 | 0.09x | $80.97 Million | $64.02 Million | $855.17 Million | ▼ -69.2% |
| 2023 | 0.31x | $137.47 Million | $118.96 Million | $446.82 Million | ▲ +979.4% |
| 2022 | -0.03x | $-14.75 Million | $-31.20 Million | $421.55 Million | ▼ -153.6% |
| 2021 | 0.07x | $26.96 Million | $3.32 Million | $412.86 Million | ▼ -79.3% |
| 2020 | 0.31x | $83.59 Million | $15.27 Million | $265.49 Million | ▲ +5.0% |
| 2019 | 0.30x | $73.18 Million | $45.63 Million | $244.00 Million | ▼ -10.3% |
| 2018 | 0.33x | $77.99 Million | $67.07 Million | $233.34 Million | ▼ -46.2% |
| 2017 | 0.62x | $147.41 Million | $39.42 Million | $237.38 Million | ▼ -46.1% |
| 2016 | 1.15x | $176.53 Million | $27.47 Million | $153.22 Million | ▲ +188.8% |
| 2015 | 0.40x | $49.95 Million | $17.26 Million | $125.18 Million | ▼ -14.4% |
| 2014 | 0.47x | $57.79 Million | $22.03 Million | $123.92 Million | ▲ +131.2% |
| 2013 | -1.50x | $-5.29 Million | $-5.48 Million | $3.54 Million | ▲ +35.8% |
| 2012 | -2.33x | $-24.67 Million | $-25.28 Million | $10.59 Million | ▼ -21.3% |
| 2011 | -1.92x | $-47.15 Million | $-47.87 Million | $24.56 Million | ▼ -22.8% |
| 2010 | -1.56x | $-40.03 Million | $-40.10 Million | $25.62 Million | ▼ -76.3% |
| 2009 | -0.89x | $-18.27 Million | $-18.43 Million | $20.61 Million | ▲ +77.1% |
| 2008 | -3.86x | $-14.88 Million | $-15.54 Million | $3.85 Million | ▼ -861.1% |
| 2007 | 0.51x | $769.42K | $739.99K | $1.52 Million | ▲ +144.0% |
| 2006 | -1.15x | $-4.96 Million | $-5.00 Million | $4.30 Million | ▲ +61.4% |
| 2005 | -2.99x | $-8.23 Million | $-8.30 Million | $2.76 Million | ▲ +44.9% |
| 2004 | -5.42x | $-10.34 Million | $-10.44 Million | $1.91 Million | ▲ +13.3% |
| 2003 | -6.26x | $-5.51 Million | $-5.52 Million | $881.21K | ▼ -100.3% |
| 2002 | -3.12x | $-3.92 Million | $-3.96 Million | $1.26 Million | ▼ -66.8% |
| 2001 | -1.87x | $-1.74 Million | $-1.82 Million | $927.76K | ▲ +44.3% |
| 2000 | -3.36x | $-3.16 Million | $-3.21 Million | $941.26K | ▲ +38.0% |
| 1999 | -5.42x | $-1.78 Million | $-1.79 Million | $329.12K | ▼ -52.0% |
| 1998 | -3.57x | $-2.92 Million | $-3.04 Million | $817.91K | — |